Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High-dose versus Low-dose Intravenous Nitroglycerin in Sympathetic Crashing Acute Pulmonary Edema
TCTR20240923005Phase 4Completed
- Sponsor
- Routine to Research Unit
- Start
- Nov 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of nitroglycerin in acute pulmonary edema (APE), sponsored by Routine to Research Unit. Started Nov 2024; status: completed.
02
Drugs
nitroglycerin
03
Conditions
acute pulmonary edema (APE)
Beyond the preview
Go deeper on TCTR20240923005.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20240923005.